KR101643385B1 - Method for preparing pills with aronia and pills by the method - Google Patents
Method for preparing pills with aronia and pills by the method Download PDFInfo
- Publication number
- KR101643385B1 KR101643385B1 KR1020160057712A KR20160057712A KR101643385B1 KR 101643385 B1 KR101643385 B1 KR 101643385B1 KR 1020160057712 A KR1020160057712 A KR 1020160057712A KR 20160057712 A KR20160057712 A KR 20160057712A KR 101643385 B1 KR101643385 B1 KR 101643385B1
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- herbal
- aronia
- medicinal
- medicinal herb
- Prior art date
Links
- 241001444063 Aronia Species 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 21
- 239000006187 pill Substances 0.000 title abstract 7
- 239000000843 powder Substances 0.000 claims abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000001035 drying Methods 0.000 claims abstract description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 17
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 14
- 238000000465 moulding Methods 0.000 claims abstract description 9
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019991 rice wine Nutrition 0.000 claims abstract description 6
- 241000411851 herbal medicine Species 0.000 claims description 39
- 240000007594 Oryza sativa Species 0.000 claims description 12
- 235000007164 Oryza sativa Nutrition 0.000 claims description 12
- 235000009566 rice Nutrition 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 230000002363 herbicidal effect Effects 0.000 claims description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 239000012676 herbal extract Substances 0.000 claims description 6
- 241001105098 Angelica keiskei Species 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 239000004009 herbicide Substances 0.000 claims description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
- 235000014347 soups Nutrition 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 235000020007 pale lager Nutrition 0.000 claims description 2
- 230000008447 perception Effects 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 4
- 241000196324 Embryophyta Species 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 abstract description 8
- 235000008216 herbs Nutrition 0.000 abstract description 6
- 239000013543 active substance Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 4
- 241000382455 Angelica sinensis Species 0.000 abstract description 2
- 235000004879 dioscorea Nutrition 0.000 abstract description 2
- 238000007598 dipping method Methods 0.000 abstract description 2
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 3
- 239000011369 resultant mixture Substances 0.000 abstract 3
- 241000132003 Atractylis Species 0.000 abstract 1
- 235000005903 Dioscorea Nutrition 0.000 abstract 1
- 244000281702 Dioscorea villosa Species 0.000 abstract 1
- 235000000504 Dioscorea villosa Nutrition 0.000 abstract 1
- 241001521474 Liriope <hydrozoan> Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract 1
- 239000009588 dong quai Substances 0.000 abstract 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 235000015872 dietary supplement Nutrition 0.000 description 9
- 235000010208 anthocyanin Nutrition 0.000 description 7
- 239000004410 anthocyanin Substances 0.000 description 7
- 229930002877 anthocyanin Natural products 0.000 description 7
- 150000004636 anthocyanins Chemical class 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 3
- 240000000851 Vaccinium corymbosum Species 0.000 description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 3
- XAQHXGSHRMHVMU-UHFFFAOYSA-N [S].[S] Chemical compound [S].[S] XAQHXGSHRMHVMU-UHFFFAOYSA-N 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 235000021028 berry Nutrition 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 235000021014 blueberries Nutrition 0.000 description 3
- -1 cadenine Chemical class 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940126601 medicinal product Drugs 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 239000000052 vinegar Substances 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 240000001810 Angelica gigas Species 0.000 description 2
- 235000018865 Angelica gigas Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000234435 Lilium Species 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000015241 bacon Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000383638 Allium nigrum Species 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 240000005662 Aronia melanocarpa Species 0.000 description 1
- 235000007425 Aronia melanocarpa Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000068485 Convallaria majalis Species 0.000 description 1
- 235000009046 Convallaria majalis Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000008955 Dioscorea japonica Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000001362 Fetal Growth Retardation Diseases 0.000 description 1
- 206010070531 Foetal growth restriction Diseases 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010024214 Lenticular opacities Diseases 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 244000018764 Nyssa sylvatica Species 0.000 description 1
- 235000003339 Nyssa sylvatica Nutrition 0.000 description 1
- 241001400472 Omiza Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 201000004810 Vascular dementia Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229920000392 Zymosan Polymers 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000021019 cranberries Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000030941 fetal growth restriction Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000006049 herbal material Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- KNMNNEPMKDJBDW-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CCNC(C)COC1=C(C)C=CC=C1C KNMNNEPMKDJBDW-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 230000003032 phytopathogenic effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A23L1/3002—
-
- A23L1/0026—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 아로니아 한방환의 제조방법 및 그 한방환에 관한 것으로, 더욱 상세하게는 항산화 활성이 우수한 아로니아와 각종 유효물질을 고르게 포함하는 한약재를 이용하여 환을 제조하는 방법에 관한 것이다.The present invention relates to a process for producing a one-ring aromatic ring, and more particularly, to a process for producing a ring using a herbicide having an excellent antioxidative activity and a herbicide which uniformly contains various active substances.
아로니아(aronia melanocarpa)는 동유럽, 북아메리카 등이 원산지로서, C3G(cyanidine-30O glycoside), 카데킨, 베타카로틴, 라이코펜, 루테인 등을 다량 함유하고 있다. 특히 상기 아로니아는 지구상 현존하는 베리류 과일 중 안토시아닌과 카데킨 함유량이 단연 최고이며, 폴리페놀 함유량도 타의 추종을 불허할 정도로 높은 것으로, 아사이베리의 4.6배, 블루베리의 5배, 크랜베리 및 복분자의 20배, 포도의 80배 이상의 안토시아닌 함유량을 갖는다. Aronia melanocarpa originates from Eastern Europe and North America and contains a large amount of C3G (cyanidine-30O glycoside), cadecine, beta-carotene, lycopene and lutein. In particular, the above-mentioned Aronia has the highest anthocyanin and cadecin content among the berries present on the earth, and the content of polyphenols is 4.6 times higher than that of Asai berries, 5 times higher than blueberries, 20 times higher than those of cranberries and brambles It has an anthocyanin content of 80 times or more that of pears and grapes.
상기 아로니아의 안토시아닌과 폴리페놀 성분은 신장기능 및 면역력을 강화시키며, 인체 내의 세포재생에 관여하여 인체 내의 병인세포 방어 체계를 조절하고, 아로니아 성분 중의 오메가3, 안토시아닌, 카데킨, 비타민, 칼슘 등은 눈에 관여하여 눈의 독소를 제거하며, 안구건조증개선, 로돕신생합성 촉진작용, 수정체혼탁 예방의 효과가 있으며, 세포복구, 암, 염증완화의 효능을 나타낸다. 또한, 아로니아에 함유된 사과산(아로니아 100g당 1300mg)은 몸 안에 축적된 칼슘의 분해를 돕고, 관절염 완화에 도움을 주며, 신체 내 pH 농도를 맞춰 균형을 이루게 하고, 혈액 내 산소를 보내주어 소화를 돕고 면역력을 증강시킨다. 그리고 독성을 해독하여 간장과 신장의 기능을 도와 허함을 보호하는 보음효과가 있다.The anthocyanin and polyphenol components of the above-mentioned Aronia enhance the kidney function and the immunity, regulate the cell defense system in the body by participating in the cell regeneration in the human body, and control omega 3, anthocyanin, cadenine, vitamin, calcium Is involved in the eye to remove toxins from the eye, has the effect of improving the dryness of the eye, facilitating the biosynthesis of rhodopsin, preventing lens opacity, and exhibiting the effects of cell repair, cancer, and inflammation relief. In addition, the malic acid contained in Aronia (1300mg per 100g of Aronia) helps to break down accumulated calcium in the body, helps to relieve arthritis, adjusts the pH in the body to balance and sends oxygen in the blood Helps digestion and strengthens immunity. And there is a noise effect that detoxifies and protects the function of the liver and kidneys.
한편, 현대인들은 과중한 업무, 과음, 과로, 불규칙한 식사, 운동부족, 스트레스, 공해 및 기타 외부 환경요인 등으로 인하여 인체의 면역력이 날로 저하되고 있다. 이처럼 인체의 면역기능이 저하된다는 것은 건강과 직결된 문제라고 할 수 있다. On the other hand, the immunity of the human body is deteriorating due to heavy work, excessive drinking, overwork, irregular eating, lack of exercise, stress, pollution and other external environmental factors. Such a decrease in the immune function of the human body is a problem directly related to health.
따라서, 현대인들은 앞으로 발생할지 모르는 건강의 적신호와 건강의 이상에 대비하여 인체의 면역력을 증진시키기 위한 온갖 수단을 강구하고 있으며, 실제로도 건강을 지키기 위한 시간의 투자와 함께 경제적인 부분에서도 많은 지출이 따르고 있다. Therefore, modern people are taking all kinds of measures to improve the immune system of the human body in order to prepare for the health signal and health abnormality that may occur in the future. In fact, have.
인체의 면역력을 증진시키기 위해 현대인들이 가장 노력하고 있는 것이 운동과 건강보조식품의 복용이라 할 수 있다. 이러한 운동과 건강보조식품의 경우는 시간과 경제적인 부담이 다른 것에 비해 덜하기 때문에 건강을 지키기 위한 수단으로써 가장 애용되고 있다.The most active effort by modern people to improve the body 's immunity is to take exercise and health supplements. These exercises and health supplements are most often used as a means of maintaining health because they are less time and economic burdens than others.
특히, 건강보조식품의 경우는 수많은 종류의 것들이 우리의 생활 주변에 즐비하기 때문에 자신의 건강상태나 취향에 따라 골라서 복용할 수 있다. 이러한 건강보조식품은 신체의 육체적, 생리적 측면에서 유용성을 기대하여 섭취할 목적으로 식품 소재에 함유된 성분을 그대로 원료로 하거나 이들에 들어 있는 특정 성분을 분리 또는 추출, 농축, 정제, 혼합 등의 방법으로 제조 가공한 식품을 말하는 것이다. Especially, in the case of health supplements, many kinds of things are around our life, so they can be taken according to their health condition or taste. These health supplements are intended to be used for the purpose of consuming in the physical and physiological aspects of the body, in order to consume the ingredients contained in the food material as they are, or to separate or extract specific components contained therein, concentrate, refine, Which is manufactured and processed.
그러나 이러한 건강보조식품은 액상의 진공포장으로 시중에 유통되고 있는 것이 대부분이어서, 복용이나 휴대에 있어 많은 불편함이 따르고 있다. 특히, 액상을 싫어하는 사람은 복용에 어려움이 있고, 휴대하는 경우도 액상의 진공포장은 많은 제약을 받게 된다.However, most of these health supplements are distributed in the market as liquid vacuum packs, and many inconveniences are involved in taking and carrying them. In particular, people who do not like liquids have difficulties in taking them, and even when carrying them, liquid-phase vacuum packaging is subject to many restrictions.
따라서, 이러한 문제점을 해결하기 위해 환(丸) 형의 건강보조식품들이 출시됨에 따라 복용의 불편함이나 휴대의 불편함을 해소하였다.Therefore, in order to solve such a problem, circulation type health supplement foods have been released, thereby solving the inconvenience of taking or the inconvenience of carrying.
상기한 환 형의 건강보조식품으로는 다음과 같은 종래기술들이 있다.As the above-mentioned annular health supplement food, there are the following conventional techniques.
먼저, 대한민국 등록특허 제10-0705740호는 유산균 및 청국장을 제환기를 이용하여 환으로 성형하고, 건조하여 기능성의 환을 제조하는 방법을 제안하였다. 또한, 대한민국 등록특허 제10-1083458호에서는 흑마늘을 유효성분으로 하는 환의 제조방법이 제안되었는바, 흑마늘, 아가콩, 알파미를 일정한 비율로 혼합하여 반죽하고, 압출하여 환을 제조하는 방법을 제안하였다. 그리고 대한민국 등록특허 제10-1552389호에서는 초마늘과 죽염을 이용하여 환을 제조하는 방법을 제안하였다.First, Korean Patent No. 10-0705740 proposes a method of molding a lactic acid bacterium and a cheonggukjang into a ring using a ventilator and drying to produce a functional ring. Korean Patent No. 10-1083458 proposes a method for producing a ring containing black garlic as an active ingredient and suggests a method for producing a ring by mixing black gum, Respectively. Korean Patent No. 10-1552389 proposes a method of manufacturing a ring using ginger and bamboo salt.
상기한 제조방법들은 모두 건강보조식품의 복용 및 휴대의 불편함을 해소한 것이다.All of the above-described manufacturing methods solve the inconvenience of taking and carrying health supplement foods.
그러나 이러한 선행기술들 중 항산화 활성이 우수한 아로니아를 활용하여 환을 제조한 예를 찾아볼 수 없었다. However, none of these prior arts have been able to find an example of manufacturing a ring utilizing the aronia having excellent antioxidant activity.
따라서, 본 발명자는 원산지는 외국이나 근래 국내에서 다량 재배되고 있는 아로니아가 국내의 한방재료와도 그 기능 및 풍미가 잘 어우러짐에 착안하여 본 발명을 완성하였다. Accordingly, the present inventor has completed the present invention in view of the fact that Aronia, which is cultivated in a large amount in a foreign country or a domestic in recent years, has a good function and flavor with domestic herbal materials.
따라서, 본 발명의 목적은 아로니아를 이용하여 환을 제조하되, 한약재를 특성에 맞게 가공, 배합함으로써, 우수한 항산화 효능을 갖도록 하는 것은 물론, 아로니아의 생리활성물질의 효능을 더욱 극대화하는 것이다.Accordingly, an object of the present invention is to produce a ring using Aronia, and to produce an excellent antioxidant efficacy by processing and compounding herbal medicines according to the characteristics, and further maximizing the efficacy of physiologically active substances of Aronia.
또한, 아로니아 및 한약재의 복용 편의성을 제공하며, 맥주효모를 배합하여 섭취자의 장내 환경을 개선함으로써, 대사를 원활하게 하고, 환의 보존성 역시 우수하게 하는 것이다. In addition, it provides the convenience of taking Aronia and herbal medicines, and improves the intestinal environment of the recipient by blending brewer's yeast, so that the metabolism is smooth and the preservation of the ring is also excellent.
또한, 외국원산인 베리류, 특히 국내에서 생산이 가능한 아로니아와 국내의 한약재를 상호 조합함으로써, 고부가가치를 창출할 수 있도록 하는 것이다.In addition, it is possible to create high added value by combining berries, which are foreign origin, especially Aronia, which can be produced domestically, and domestic herbal medicines in Korea.
상기한 목적을 달성하기 위한 본 발명의 아로니아 한방환의 제조방법은, 아로니아를 건조하고, 분쇄하는 단계와, 산약, 오미자, 구기자, 산사육, 맥문동을 포함하는 제1한약재를 건조하고 분쇄하여 한약재 분말을 제조하는 단계와, 숙지황을 물에 20~40분간 침지시킨 후, 쌀막걸리와 혼합하고 가열하여 죽화하는 단계와, 맥아, 당귀, 백출, 백작약, 백봉령을 포함하는 제2한약재에 물을 가하고 가열하여 한약재 추출액을 제조하는 단계와, 상기 죽화한 숙지황, 상기 한약재 분말 및 상기 한약재 추출액, 상기 아로니아 분말 및 건조맥주효모를 혼합하는 단계와, 상기 혼합한 혼합물을 환으로 성형하는 단계를 포함하는 것을 특징으로 한다.In order to accomplish the above object, the present invention provides a method for manufacturing a one-component herbicidal composition comprising the steps of drying and crushing a herbarium, and drying and crushing a first herb medicament containing a lily of the month, omija, Preparing a powder; dipping the safflower in water for 20 to 40 minutes, mixing with rice rice wine, heating and dying; and adding water to a second herbal medicine including malt, Angelica keiskei, Preparing an aqueous solution of herbal medicines by heating the mixture; mixing the dried medicinal herb, the medicinal herb powder, the medicinal material extract, the aronia powder and dry brewer's yeast; and molding the mixed mixture into a ring .
상기 제1한약재는 길경 및 지각을 더 포함하고, 상기 제2한약재는 어성초 및 속단을 더 포함하는 것을 특징으로 한다.The first herbal medicine material may further include a root length and a perception angle, and the second herbal medicine material may further include a primordial gland and a gland.
상기 제1한약재는 건조 전, 30~120초간 끓는 물에 살균하는 단계를 포함하는 것을 특징으로 한다.And sterilizing the first herbal medicine with boiling water for 30 to 120 seconds before drying.
상기 죽화한 숙지황, 상기 한약재 분말 및 상기 한약재 추출액, 상기 아로니아 분말 및 건조맥주효모를 혼합하는 단계는, 상기 죽화한 숙지황 5~10중량%, 상기 한약재 분말 5~10중량%, 상기 한약재 추출액 5~10중량%, 아로니아 분말 60~80중량% 및 건조맥주효모 3~10중량%의 비율로 혼합하는 것을 특징으로 한다.The step of mixing the above-mentioned dyed Sulfur Sulfur, the herbal powder and the herbal extract, the Aronia powder and the dry brewer's yeast comprises mixing 5 to 10% by weight of the killed Sulfuric Acid, 5 to 10% by weight of the herbal powder, 5 to 10% 10 to 10 wt% of the powder, 60 to 80 wt% of the Aronia powder, and 3 to 10 wt% of the dried beer yeast.
그리고 본 발명에 의한 아로니아 한방환은, 상기한 방법들로 제조되는 것을 특징으로 한다.The one-ring Aronian ring according to the present invention is characterized by being manufactured by the above-mentioned methods.
본 발명에 의하면, 아로니아와 한약재를 재료특성에 맞도록 가공하여 배합함으로써, 각 재료가 갖는 생리활성물질의 효능을 극대화하고, 남녀노소 누구나 손쉽게 섭취할 수 있도록 하는 장점이 있다. 또한, 환의 보존성 역시 증대시키는 장점이 있다.According to the present invention, it is possible to maximize the efficacy of the physiologically active substance of each material and make it easy for anyone, both young and old, to easily ingest, by processing and mixing the aronia and herbal medicines in accordance with the material characteristics. It also has the advantage of increasing the shelf life of the rings.
도 1은 본 발명에 따른 아로니아 한방환의 제조공정도.1 is a view showing a manufacturing process of a one-ring Arrangement according to the present invention.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에 따른 아로니아 한방환은 우수한 항산화 효능을 갖는 것은 물론, 아로니아 및 한약재가 갖는 다양한 유효성분을 손쉽게 섭취할 수 있는 건강보조식품이다.The herbicidal composition according to the present invention has not only excellent antioxidative effect but also various dietary ingredients of aronia and herbal medicines.
이러한 본 발명의 아로니아 한방환은 아로니아를 주재료로 하여 제조하는 것으로, 상기 아로니아는 앞서 설명된 바와 같이, 안토시아닌과 폴리페놀 등의 기능성 물질을 다량 함유하여, 우수한 항산화 특성을 보이는 것은 물론, 면역력을 증강시키고, 독성을 해독하며, 암 및 염증을 완화하는 등의 작용을 한다. As described above, the aronia contains a large amount of functional substances such as anthocyanin and polyphenol, exhibits excellent antioxidative properties, and also has immunity , To detoxify toxins, and to alleviate cancer and inflammation.
또한, 본 발명의 아로니아 한방환은 다양한 한약재를 사용하는데, 종래와 같이 모든 한약재를 분말화하고, 이를 곡물가루에 혼합하여 환을 제조하는 것과는 달리, 한약재의 특성에 맞게 그 가공방법을 달리하여 환을 제조함을 특징으로 한다. 이는 일반적으로 오미자나 마, 구기자와 같이 그냥 먹어도 되는 한약재가 있는 반면, 탕액으로 우려내어 약액을 복용하여야 하는 한약재가 있기 때문이며, 이러한 한약재를 통해 오장을 보하여 아로니아의 흡수를 극대화하는 것이다.Unlike conventional herbal medicine, in which all herbal medicines are pulverized and mixed with a grain powder to produce a ring, the herbicidal composition of the present invention uses various herbal medicines, Is produced. This is because, in general, there are herbal medicines that can be eaten just like Omija, Ma, and Gugija, but there are herbal medicines that need to be taken out of the bath fluid and take medicinal solution.
이러한 본 발명에 따른 아로니아 한방환의 제조방법은, 아로니아를 건조하고, 분쇄하는 단계와, 산약, 오미자, 구기자, 산사육, 맥문동을 포함하는 제1한약재를 건조하고 분쇄하여 한약재 분말을 제조하는 단계와, 숙지황을 물에 20~40분간 침지시킨 후, 쌀막걸리와 혼합하고 가열하여 죽화하는 단계와, 맥아, 당귀, 백출, 백작약, 백봉령을 포함하는 제2한약재에 물을 가하고 가열하여 한약재 추출액을 제조하는 단계와, 상기 죽화한 숙지황, 상기 한약재 분말 및 상기 한약재 추출액, 상기 아로니아 분말 및 건조맥주효모를 혼합하는 단계와, 상기 혼합한 혼합물을 환으로 성형하는 단계를 포함하는 것을 특징으로 한다.The method for producing the Arrancia herbicidal ring according to the present invention comprises the steps of drying and pulverizing Aronia, and drying and pulverizing the first herb medicinal material containing lily of the month, omija, gugija, And a step of mixing the rice bran with water for 20 to 40 minutes and then mixing and heating the rice bran and heating and adding water to the second herb medicinal material including malt, Angelica keiskei, And mixing the crude medicinal herb, the medicinal herb powder, the herbal extract, the Aronia powder and the dry brewer's yeast, and molding the mixed mixture into a ring.
이하, 본 발명의 제조방법을 첨부된 도 1을 참조하여 상세히 설명한다.Hereinafter, a manufacturing method of the present invention will be described in detail with reference to FIG. 1 attached hereto.
아로니아를Aronia 건조하고, 분쇄하는 단계. Drying, and grinding.
먼저, 아로니아를 깨끗이 세척하여 건조하고, 이를 분쇄하여 분말로서 가공한다. 이때, 상기 건조 및 분쇄방법은 종래 공지된 방법에 따르며, 분말의 입도는 제한하지 않는다. 다만, 그 건조방법으로는 30~40℃의 온도로 저온건조하는 것이ㄱ가장 바람직하며, 그 입도는 환으로의 성형을 용이하게 하기 위하여 100~300mesh 정도임로 분쇄함이 가장 적합하다.First, Aronia is cleaned, dried, ground, and processed as a powder. At this time, the drying and grinding method is performed according to a conventionally known method, and the particle size of the powder is not limited. However, as the drying method, it is most preferable to perform low-temperature drying at a temperature of 30 to 40 ° C, and the particle size is most preferably 100 to 300mesh in order to facilitate molding into a ring.
상기 아로니아는 환의 주재료로서 항산화, 면역력, 항암 등의 효능이 있다..The above-mentioned Aroonia is a main ingredient of the ring, and has antioxidant, immunity and anticancer effects.
산약Light , 오미자, 구기자, , Omija, Gujiya, 산사육Mountain feeding , 맥문동을 포함하는 , Including marshmallow 제1한약재를First herbal medicine 건조하고 분쇄하여 한약재 분말을 제조하는 단계. Drying and pulverizing to prepare a medicinal herb powder.
다음으로, 산약, 오미자, 구기자, 산사육, 맥문동을 포함하는 제1한약재를 건조하고 분쇄한다. 여기서, 상기 제1한약재는 모두 탕액을 우려내지 않고, 그대로 섭취가 가능한 한약재로서, 상기 건조 및 분쇄 방법은 제한하지 않는다. 그리고 상기 제1한약재 역시 아로니아 분말과 같이, 그 분쇄 입도를 반드시 제한하는 것은 아니나, 환으로의 성형을 용이하게 하기 위하여 100~300mesh 정도로 분쇄함이 가장 적합하다.Next, the first medicinal herb including the lily of the valley, the omija, the gugija, the mountain raising meat, and the mukmundong is dried and crushed. Here, all of the first herbal medicines are herbal medicines which can be ingested without concern for a bath liquid, and the drying and pulverizing methods are not limited. In addition, the first herbal medicine material, like the Aronia powder, is not necessarily limited in its particle size, but it is most suitable to be pulverized to about 100 to 300 mesh in order to facilitate molding into a ring.
또한, 상기 제1한약재는 건조 전, 30~120초간 끓는 물에 살균하는 단계를 포함할 수 있는데, 이는 한약재에 혹시 남아있을 수 있는 곰팡이, 세균 등을 제거하기 위한 작업이다. 상기 살균은 제1한약재를 끓는 물에 30~120초간 데쳐내는 작업만으로 충분하다.In addition, the first medicinal herb may be sterilized by boiling water for 30 to 120 seconds before drying, which is an operation for removing fungi and bacteria which may possibly remain in the medicinal herb. The sterilization is sufficient for the first herbal medicine to boil in boiling water for 30 to 120 seconds.
그리고 상기 제1한약재로서 길경 및 지각을 더 포함할 수도 있는데, 길경 및 지각을 통해 제1한약재는 물론, 아로니아, 숙지황 및 제2한약재의 작용을 돕는다.Also, the first medicinal herb may further include gill gill and crust. Through the medicinal herb and the crust, the first medicinal herb as well as the auria, the medicinal herb and the second medicinal herb are supported.
상기 제1한약재는 산약, 오미자, 구기자, 산사육, 맥문동, 길경 및 지각을 1: 0.5~1.5: 0.5~1.5: 0.3~1.0: 0.5~1.5: 0.1~1: 0.1~1 중량비 정도로 혼합하여 사용하는 것이 가능하며, 가장 바람직하게는 1: 1: 1: 0.5: 1: 0.5: 0.2 중량비로 하는 것이다. The first medicinal herb is used in an amount of about 1: 0.5 to 1.5: 0.5 to 1.5: 0.3 to 1.0: 0.5 to 1.5: 0.1 to 1: 0.1 to 1 by weight in the range of 1: 0.5 to 1.5: 0.5 to 1.5: 0.3 to 1: 1: 1: 0.5: 1: 0.5: 0.2 weight ratio.
상기 제1한약재에 대한 효능에 대해서는 하기에서 다시 설명한다.The efficacy of the first medicinal herb will be described later.
숙지황을 물에 20~40분간 20 ~ 40 minutes in water 침지시킨Immersed 후, 쌀막걸리와 혼합하고 가열하여 After, the rice was mixed with makgeolli and heated 죽화Kyu 하는 단계..
다음으로, 숙지황을 물에 20~40분간 침지시켜 불순물을 제거한 후, 이에 쌀막걸리를 혼합하고 60~90℃로 가열하여 죽화한다. 이때, 상기 쌀막걸리는 숙지황의 5~20중량 배만큼 투입하며, 상기 가열시간은 제한하지 않지만 투입된 쌀막걸리가 1/2~1/10 부피비 정도로 줄어들 때까지 농축한다. 그리고 상기 농축액으로부터 숙지황의 잔여 고형분은 제거하여 사용한다.Next, the raw pork slices are immersed in water for 20 to 40 minutes to remove impurities, then rice rice wine is mixed and heated to 60 to 90 ° C for dying. At this time, the rice makgeolli is added by 5 to 20 times by weight of the safflower, and the heating time is not limited, but the rice is concentrated until the rice wine is reduced to about 1/2 to 1/10 volume ratio. The residual solids of Sulfur Sulfur are removed from the concentrate and used.
본 발명에서는 별도의 콩가루나 곡물가루를 이용하지 않고 쌀막걸리를 이용하여 환을 제조하는 것인바, 쌀막걸리는 환으로의 성형성을 좋게 하는 것은 물론, 베타시토스테롤이 다량 함유되어 위암세포의 성장을 억제하고, 종양의 크기를 줄이는 효과가 있기 때문이다. 또한, 상기 숙지황은 점성 물질을 포함하므로, 바인더로서 작용이 용이하다.In the present invention, rice is made by using rice rice wine without using any other flour or grain powder. Rice makgeol not only improves the moldability to the ring, but also contains a large amount of beta-sitosterol, And to reduce the size of the tumor. In addition, since Sulfur Sulfur contains a viscous substance, its action as a binder is easy.
맥아, 당귀, 백출, 백작약, 백봉령을 포함하는 Including malt, Angelica gigas, Baekje, Baekjaek, Baekbyeong 제2한약재에In the second herbal medicine 물을 가하고 가열하여 한약재 추출액을 제조하는 단계. Adding water and heating to prepare an extract of the medicinal herb.
다음으로, 한약재의 특성상 분말로서 섭취할 경우 인체에 이롭지 못한 제2한약재를 열수추출하여 한약재 추출액을 제조한다.Next, according to the characteristics of the herbal medicine, the second herbal medicine which is not beneficial to the human body when taken as a powder is extracted with hot water to prepare the herbal medicine extract.
이러한 제2한약재로는 맥아, 당귀, 백출, 백작약, 백봉령 사용하는바, 이에 10~20중량배의 물을 가하고, 60~100℃로 5~24시간 가열하여 추출액을 제조하는 것이다. 상기 열수추출방법 및 시간은 이미 이 기술이 속하는 분야에서 충분히 공지된 것이므로, 이에 대한 상세한 설명은 생략한다.Examples of the second herb medicine include maltose, Angelica keiskei koidz., White liquorice, white peach, and bacon, and 10 to 20 times by weight of water is added thereto and heated at 60 to 100 ° C for 5 to 24 hours to prepare an extract. Since the hot water extraction method and time are already well known in the field to which this technology belongs, a detailed description thereof will be omitted.
또한, 상기 제2한약재로서 어성초 및 속단을 더 포함할 수 있는데, 어성초와 속단을 통해 아로니아의 소화, 흡수를 더욱 돕는 것이다.In addition, the second medicinal herb may further include an adult herb and a hereditary herb, which further helps digestion and absorption of the arnia through the herb and herb.
상기 맥아, 당귀, 백출, 백작약, 백봉령, 어성초 및 속단은 0.5: 0.5~1.5: 0.5~1.5: 0.1~1.0: 0.1~1.0: 0.1~0.5: 0.1~0.5 중량비로 사용 가능하며, 가장 바람직하게는 0.5: 1: 1: 0.5: 0.5: 0.2: 0.2 중량비로 사용한다.The malt extract may be used at a weight ratio of 0.5: 0.5 to 1.5: 0.5 to 1.5: 0.1 to 1.0: 0.1 to 1.0: 0.1 to 0.5: 0.1 to 0.5, 0.5: 1: 1: 0.5: 0.5: 0.2: 0.2 weight ratio.
상기 제2한약재의 효능에 대해서도 하기에서 다시 설명한다. The efficacy of the second medicinal herb will be described again below.
상기 remind 죽화한Dying 숙지황, 상기 한약재 분말 및 상기 한약재 추출액, 상기 The medicinal herb powder, the herbal medicine extract, 아로니Aroni 아 분말 및 건조맥주효모를 혼합하는 단계.Step of mixing egg powder and dry beer yeast.
다음으로, 앞서 준비해둔 죽화한 숙지황, 한약재 분말 및 한약재 추출액을 혼합하고, 이에 다시 앞서 준비해둔 아로니아 분말과 건조맥주효모를 혼합한다. 이때, 그 혼합비는 상기 죽화한 숙지황 5~10중량%, 상기 한약재 분말 5~10중량%, 상기 한약재 추출액 5~10중량%, 아로니아 분말 60~80중량% 및 건조맥주효모 3~10중량% 정도면 족하다.Next, the above-prepared mushroom soup, the herbal medicine powder and the herbal medicine extract solution are mixed, and then the previously prepared aronia powder and dry brewer's yeast are mixed. At this time, the blending ratio is 5 to 10% by weight of the above-mentioned chopped steamed sulfur, 5 to 10% by weight of the herbal powder, 5 to 10% by weight of the herbal extract, 60 to 80% It is enough.
여기서, 상기 건조맥주효모는 양질의 필수아미노산을 다량 포함하여 단백질의 공급원이 되며, 셀레늄, 베타글루칸, 판감산, 칼륨, 크롬, 아연, 이아신, 판감산, 콜린, 식물성 다당체 등을 다량 함유하며, 아로니아, 한약재 등과 혼합 사용시 효모의 유효성분을 통해 장내 환경을 좋게 하여 대사를 원활하게 함으로써, 아로니아와 한약재의 효능을 극대화한다. 아울러, 효모의 작용을 통해 환의 보존성을 높일 수 있다.The dried brewer's yeast contains a large amount of high quality essential amino acids and is a source of protein and contains a large amount of selenium, betaglucan, plate reduction, potassium, chromium, zinc, , Aronia and herbal medicines, it improves the intestinal environment through the active ingredient of yeast and smoothes metabolism, maximizing the efficacy of Aronia and herbal medicines. In addition, the preservation of the ring can be enhanced through the action of the yeast.
상기 혼합한 혼합물을 환으로 성형하는 단계.And molding the mixed mixture into a ring.
그리고 상기 혼합한 혼합물을 환으로 성형한다. 상기 환으로의 성형 방법은 종래 공지된 방법, 즉 제환기 등을 이용하며, 환의 크기, 즉 환의 직경을 제한하지 않는다. Then, the mixed mixture is formed into a ring. The method of molding into the ring uses a conventionally known method, that is, a ventilator, and does not limit the size of the ring, that is, the diameter of the ring.
상기한 방법으로 제조된 본 발명의 아로니아 한방환은 항산화 및 면역력 증강효과가 우수하여, 섭취자의 건강증진에 도움을 주는 것은 물론, 각 재료의 특성에 맞는 가공방법으로 독성이 없으며, 남녀노소 누구나 손쉽게 섭취할 수 있는 장점이 있다. 특히, 아로니아와 함께 배합된 한약재가 오장에 고루 영양을 주고, 서로 상보하여 아로니아의 효능을 좀 더 강화시키며, 체내에 원활하게 소화흡수되도록 하는 것을 도와 그 효능을 배가시키는 것이다.The herbicidal preparation of the present invention produced by the above-mentioned method has excellent antioxidant and immunity-enhancing effect, which not only helps the health of the consumer, but also has no toxicity due to the processing method suited to the characteristics of each material. There is an advantage that can be ingested. Especially, herbal medicines formulated with Aronia will nourish the five stomachs, complement each other to strengthen the efficacy of Aronia, and help the body digest and absorb smoothly, doubling its efficacy.
본 발명의 아로니아 한방환은 건강보조식품으로서, 그 섭취량을 제한하지 않으나, 1일 3회, 1회 5~20mg 정도를 섭취할 수 있다.The herbicide of the present invention is a dietary supplement, and its intake is not limited, but it can be ingested at about 5 to 20 mg once a day, three times a day.
이하, 본 발명에서 사용한 제1한약재, 숙지황, 제2한약재, 맥주효모의 효능에 대해 더욱 상세히 설명한다.Hereinafter, the efficacy of the first medicinal herb, the medicinal herb medicine, the second medicinal herb, and the brewer's yeast used in the present invention will be described in more detail.
먼저, 본 발명에서 사용한 한약재들은 원방의 육미지황탕을 적절히 가감한 것으로, 원방의 육미지황탕은 숙지황, 산약, 산수유, 택사, 목단피, 백봉령이다. 상기 육미지황탕은 남성의 전십성, 고혈압, 당뇨에도 좋은 임상을 보이며, 위암발생억제, 성인병 예방 등에 활용되는 오래된 처방전으로, 본 발명에서는 산수유, 택사, 목단피를 구기자, 백봉령 등으로 대체하여 복용범위가 제한되거나 부작용 초래의 위험을 없애고, 그 효과를 더욱 극대화할 수 있도록 한 것이다. First, the herb medicines used in the present invention are those with a proper addition or subtraction of the original one. The above-mentioned Jami-Jiwanghang-tang is an old prescription used for the prevention of gastric cancer and prevention of adult diseases, which shows good clinical results in men's ancestry, hypertension and diabetes. In the present invention, by replacing acidic oil, phytophagus, Thereby eliminating the risk of limiting or causing side effects, and maximizing the effect.
먼저, 산약(참마, D.japonica Thunb.)은 뮤신, 알란토인, 용혈 작용이 매우 적은 사포닌, 아르기닌 등을 함유하여, 기침, 천식, 식은땀, 숨가쁨을 치료하고 허약 체질을 개선시키며, 신, 폐, 비 기능을 향상시키는 보기양음 작용을 하고, 폐허천식과 비염에 사용된다. 상기 산약은 부작용이 없고 맛에도 거부반응이 없어 대중적으로 사용하기에 가장 적합하다.First, the yam (D. japonica Thunb.) Contains mucin, allantoin, saponin with very low hemolytic activity, and arginine to cure cough, asthma, cold sweat, shortness of breath and improve weakness, , Which improves non-functioning, is used for deprivation asthma and rhinitis. The liquor has no side effects and does not have a rejection to taste, so it is most suitable for use in the public.
오미자는 신경쇠약, 간염, 기침에 좋으며, 폐에 작용하여 폐의 기를 수렴하고, 기침을 멈추게 하며, 신장에 작용하여 설사와 유정을 멈추게 하고, 인체의 진액을 보충하는 작용을 한다. 상기 오미자는 숙지황, 산수유, 구기자, 산약 등과 함께 폐와 신장을 보하는 작용을 한다. Omija is good for nervous breakdown, hepatitis, coughing, acting on the lungs to converge the lungs, stop coughing, stop the diarrhea and the wells by acting on the kidneys, and supplement the body's essence. The above-mentioned Omija has a function of displaying the lung and the kidney together with Sukjihwang, Sansui, Gugija,
구기자는 육미지황 중 순환기에 문제가 있을 수 있는 체질에겐 맞지 않는 산수유를 대체한 것으로, 베타인, 비잔틴, 올레산, 리놀레산 등의 유효성분이 풍부하다. 상기 구기자의 베타인 성분은 아로니아의 항산화 물질들과 함께, 혈관성 치매를 예방한다. 아울러, 불포화 지방산인 비잔틴은 항산화작용을 하며, 올레산은 혈관강화와 청혈작용을 하여 성인병을 예방하고, 베타인, 비잔틴, 리놀레산이 혈관벽을 강화하고 인슐린의 기능을 향상시켜, 당뇨, 치매, 간건강, 고혈압 등을 예방한다. 특히, 상기 구기자는 아로니아와 지극히 부합되는 한약재로서, 아로니아와 함께 인체 내 독소를 효율적으로 제거한다.Gugija is a substitute for corn syrup which does not fit the constitution that may cause problems in the cardiovascular system, and it has a lot of effective ingredients such as betaine, butane, oleic acid and linoleic acid. The betaine component of the guinea pig, together with the antioxidants of Aronia, prevents vascular dementia. In addition, the unsaturated fatty acid Byzantine has an antioxidant effect, and oleic acid acts as a blood vessel strengthening and a haemolytic action to prevent adult diseases. Betaine, Byzantine, and linoleic acid strengthen blood vessel walls and improve insulin function. , And hypertension. In particular, the goji is a medicinal herb that is extremely compatible with aronia, and together with aronia, efficiently removes toxins from the human body.
산사육은 주로 소화기, 순환계 질환을 다스리며, 통증에 효과가 좋다. It mainly controls digestive and circulatory diseases, and is effective for pain.
맥문동은 몸을 보하는 보익약으로, 심경, 위경, 폐경에 효과적이고, 아이들 감기에도 쓰이며, 점액질이 풍부해서 변비에도 응용된다.Macmun-dong is a beneficial medicine for the body, which is effective for heart, lung, and menopause, and also used for children's cold. It is also used for constipation because it is rich in mucus.
숙지황은 정익혈의 대표적인 약재로서 소화를 돕기 위해 백출과 함께 사용하고, 양기를 높이며 정수를 키워준다. 또한, 혈액을 만들어 몸 안을 데워주는 역할을 한다. 숙지황의 점성이 끈끈하고 소화에 부담을 주는 부작용이 있으나, 이는 백출과 당귀, 산사육으로 문제를 해결하였다.Sukjihwang is a typical medicinal product of Jungwik blood, and it is used in conjunction with Paku to help digestion. It also serves to warm the body by making blood. There is a side effect that Sukjipu's viscus is sticky and burdens on digestion, but it solved the problem with Baekjong, Angelicae, and mountain feeding.
맥아는 소화기가 허약하여 발생하는 식욕부진을 다스리며, 비경, 위경에 효과가 좋다. Malt is responsible for anorexia, which is caused by weak digestive system.
당귀는 백작약과 더불어 보혈약의 대표약재로서, 백작약의 효능을 증가시키기 위해 사용하였다. 상기 당귀는 혈이 부족한 것을 다스리는 것으로, 심혈, 혈액순환, 혈맥, 비, 간, 심경에 효능이 좋다.Angelica sinensis was used as a representative medicinal product of blood medicine in addition to the vinegar to increase the efficacy of the vinegar. The Angelica gigas regulate the lack of blood, which is good for cardiovascular, circulation, blood vessel, rain, liver and heart.
백출은 위장을 튼튼하게 하고, 비장을 안정시키며, 식욕부진, 만성 소화불량에 효과가 좋다.It is good for stomach, stabilizes the spleen, poor appetite and chronic digestive problems.
백작약은 육미지황 중 목단피를 대체하는 한약재로, 상기 목단피는 몸이 찬 사람이나 임신 중 여성, 생리량이 많은 여성에게 맞지 않아 범용으로 사용 가능한 백작약으로 대체한 것이며, 백작약의 효능 증가를 위해 당귀를 더한 것이다. 상기 백작약은 열을 식히고 혈을 기르는 청열양혈의 약재로, 진정, 향균, 혈압강하, 부종억제작용등의 효능이 있으며, 간과 비장에 작용하여 수렴작용과 해열작용, 간의 기운이 뭉친 것을 풀어주고 진통효과, 식은땀, 관절지통 등에 효능이 있다.The herbal medicine is a herb medicine substituting herringbone in Korean horse mackerel. The herring mackerel is replaced with a herbal medicine which can be used for general purposes because it is not suitable for a woman who is full of body, a woman during pregnancy, or a woman of high physiology. will be. This herbal medicine is a medicinal product of cheonggyangbang blood which keeps heat cool and raises blood and has effects such as soothing, antibacterial, blood pressure lowering, suppression of swelling and acts on liver and spleen to solve convergence, It has efficacy, eclipses, sweat, and joint pain.
백봉령은 육미지황 중 택사를 대체하는 한약재료로, 택사는 과도하게 장기간 복용할 경우 혈액순환장애 등의 위험성이 있으므로, 본 발명에서는 이를 백봉령으로 대체한 것이다. 상기 백봉령은 예로부터 강장제로 사용하였는바, 백출과 더불어 심, 비, 신, 폐경에 작용하여 비장을 보하고 정신을 안정시키며, 체내 수액대사를 원활하게 하여 이뇨작용과 진정장용, 혈당강하작용, 강장제로 활용된 약재로서 아로니아, 한약재의 흡수와 소통을 담당한다.Bacon is a herb medicine substitute for phytopathogenic fungi, and there is a risk of blood circulation disorder when phytase is taken over a long period of time. The above-mentioned bones were used as a tonic for a long time, and they acted on the heart, the rain, the kidney, and the menopause along with the redness to stabilize the spleen and the mind, It is a medicinal substance used as a tonic agent and is responsible for the absorption and communication of herbs and medicinal herbs.
또한, 어성초는 해독, 청혈 작용이 있으며, 장을 깨끗하고 건강하게 유지시킨다. 상기 어성초에 포함된 쿠에르치트린은 모세혈관의 혈액운반작용을 촉진시키고, 항염, 세포재생을 돕는다. 상기 어성초는 아토피, 피부염에도 효과가 좋다. In addition, Hwasungcho has detoxification, purulent action, and keeps the field clean and healthy. The quercetin, which is contained in the above-mentioned strains, promotes the blood-transporting action of the capillary blood vessels and helps anti-inflammation and cell regeneration. The herringbone is effective for atopic and dermatitis.
속단은 간경, 신경에 효과가 좋다.The fasting is good for liver and nerve.
길경은 폐에 작용하여 해수와 가래가 많고 호흡이 불편한 증상을 치료하며, 인후통, 기침, 가래, 코막힘, 두통, 천식, 오한 등에 사용된다.Gakyung works on the lungs to treat many symptoms of seawater and sputum and discomfort in breathing. It is used for sore throat, cough, sputum, nasal congestion, headache, asthma and chills.
지각(枳殼)은 감귤나무 또는 그 재배변종의 덜 익은 열매를 보통 반으로 자른 것으로, 폐기로 기침하는 것을 낫게 하며, 담을 삭이고, 대소장을 잘 통하게 하며, 장풍, 치질을 낫게 한다.The crust is usually cut into half of the citrus or cultivated varieties of ripe fruit, it is cured by disposal to cure, to cut the wall, to make the bulb well, and to repair the long winds and hemorrhoids.
맥주효모는 Saccharomyces cerevisiae의 1종으로, 인체에서 일어나는 약 300만 가지의 효소반응에 필요한 효소의 성분이므로, 효소성분 부족으로 생기는 중간 노폐물의 생성을 막아줌으로써 간질환에는 없어서는 안 될 중요한 제제이다. 그리고 모든 영양부족의 문제를 대부분 해결해 줄 수 있는 훌룡한 건강식품으로, 면역기능을 향상시켜 각종 암이나, 바이러스 간염을 개선시키는 작용이 있는 식물 다당체인 베타 글루칸(β-Glucan), 지모산(Zymosan) 등을 함유하고 있다. 콜린(Choline)을 함유하고 있어 숙취와 지방간에도 좋다.Brewer's yeast is Saccharomyces cerevisiae is one of the enzymes necessary for the reaction of about 3 million enzymes in the human body. It is an important ingredient for liver diseases by preventing the generation of intermediate waste caused by the lack of enzymes. It is a good health food that can solve most of the problems of malnutrition. It is a vegetable polysaccharide which has the function of improving immune function to improve various cancers and viral hepatitis, β-Glucan, Zymosan ) And so on. It contains choline and is good for hangover and fatty liver.
이하, 본 발명을 구체적인 실시예를 통해 더욱 상세히 설명한다.Hereinafter, the present invention will be described in more detail with reference to specific examples.
(제조예 1)(Production Example 1)
아로니아를 30℃에서 저온건조하고, 200mesh로 분쇄하여 아로니아 분말 900g을 준비하였다. Aronia was dried at low temperature at 30 캜, and pulverized at 200 mesh to prepare 900 g of Aronia powder.
그리고 산약 25g, 오미자 25g, 구기자 25g, 산사육 12g, 맥문동 25g을 깨끗이 세척한 후, 100℃의 끓는 물에 60초간 데쳐내고, 이를 자연건조하고 200mesh로 분쇄하였다. Then, 25 g of liquorice, 25 g of omiza, 25 g of ginger, 12 g of ginseng, and 25 g of ginseng were thoroughly washed and boiled for 60 seconds in boiling water at 100 ° C, followed by naturally dried and pulverized to 200 mesh.
또한, 숙지황 50g은 500ml의 물에 30분간 침지시킨 후, 이를 건져내 쌀막걸리 1kg에 투입하고, 이를 80℃에서 5시간 가열하여 죽화하였다. 상기 죽화한 가열물로부터 고형분을 제거하였다. 수득된 수득물은 125g 이었다.In addition, 50 g of Sukjihwang was immersed in 500 ml of water for 30 minutes, and then it was recovered and added to 1 kg of rice makgeolli, which was then heated at 80 ° C for 5 hours for killing. The solid content was removed from the above-mentioned chilled heated product. The obtained yield was 125 g.
다음으로, 맥아 12g, 당귀 25g, 백출 25g, 백작약 12g, 백봉령 12g에 1kg의 물을 가하고, 80℃로 10시간 가열하여 추출액을 제조하였다. 수득한 추출액은 120g 이었다. Then, 1 kg of water was added to 12 g of malt, 25 g of Angelica keiskei, 25 g of Vinegar, 12 g of Veterinary medicine and 12 g of bovine serum, and the mixture was heated at 80 캜 for 10 hours to prepare an extract. The extract obtained was 120 g.
그리고 상기 한약재 분말, 한약재 추출액 및 죽화하여 얻은 수득물을 모두 혼합하고, 이에 다시 상기 아로니아 분말을 혼합하였다. 그리고 건조맥주효모 60g을 충분히 혼합하고, 이를 제환기를 이용하여 환으로 성형하였다. Then, the herbal medicine powder, the herbal medicine extract solution and the obtained product obtained by dying were all mixed, and then the above-mentioned Aronia powder was mixed. Then, 60 g of dry brewer's yeast was sufficiently mixed, and the mixture was molded into a ring using a ventilator.
(실시예 2)(Example 2)
실시예1과 동일하게 실시하되,The procedure of Example 1 was repeated,
제1한약재로서 길경 12g, 지각 5g을 더 사용하고, 제2한약재로서 어성초 5g, 속단 5g을 더 사용하였다.As the first herb medicine, 12g of Gyungyang and 5g of crust were further used, and 5g of herring root and 5g of herb were further used as the second herb medicine.
(시험예 1)(Test Example 1)
항산화력 평가.Antioxidant capacity evaluation.
실시예 1, 2와 같이 제조한 환의 항산화력을 측정하였다.The antioxidant power of the rings prepared as in Examples 1 and 2 was measured.
시료의 에탄올 추출은 시료량의 9배량(w/v)의 95% 에탄올을 가하고, 상온에서 자동교반기를 이용하여 1주일 동안 교반하면서 1차 추출한 후, 여과지(Advantec No.2, Toyo Roshi Kainshm Ltd., Tokyo, Japan)를 사용하여 여과하여 rotary vacuum evaporator(EYELAA-1000S, Tokyo Rikakikai Co., Tokyo, Japan)로 40℃에서 감압농축하여 건조시킨 후 냉동보관하면서 실험에 사용하였다.The ethanol extract of the sample was prepared by adding 95% ethanol of 9 times the amount of the sample (w / v), firstly extracting it with stirring at room temperature for 1 week using an automatic stirrer, and filtering paper (Advantec No. 2, Toyo Roshi Kainshm. , Tokyo, Japan), and concentrated under reduced pressure at 40 ° C in a rotary vacuum evaporator (EYELAA-1000S, Tokyo Rikakikai Co., Tokyo, Japan).
항산화 활성 측정은 DDPH(1,1-diphenyl-2-picryhydrazyl, Sigma-Aldrich Co.)를 이용하여 시료의 라디칼 소거효과를 보는 Biois법을 활용하였다. 각 추출물을 농도별 0.625~10mg/ml로 제조한 시료 용액 1ml에 0.2mM DPPH 1ml를 넣고, vortex mixer를 사용하여 혼합하고 암실에서 30분간 반응시킨 후 517nm에서 흡광도를 측정하였다. 그리고 아래의 식을 이용하여 free radical scavenging activity 곡선을 작성한 후, IC50을 산출하였으며, 양성대조군으로 ascorbic acid를 사용하였다. To determine the antioxidant activity, the Biois method was used to examine the radical scavenging effect of DDPH (1,1-diphenyl-2-picryhydrazyl, Sigma-Aldrich Co.). 1 ml of 0.2 mM DPPH was added to 1 ml of the sample solution prepared from 0.625 to 10 mg / ml of each extract, mixed using a vortex mixer, reacted for 30 minutes in a dark room, and absorbance was measured at 517 nm. Then, free radical scavenging activity curves were generated using the following equation, and IC 50 was calculated. As a positive control, ascorbic acid was used.
Radical scavenging activity(%)={(control Absorbance - Sample Absorbance)/control Absorbance}×100Radical scavenging activity (%) = {(control Absorbance - Sample Absorbance) / control Absorbance} × 100
그 결과는 하기 표 1에 나타내었다.The results are shown in Table 1 below.
(mg.ml)IC 50
(mg.ml)
IC50 값은 추출물을 첨가하지 않은 대조군의 값을 50% 감소시키는 추출물의 농도를 나타낸 것으로, IC50 값이 작을수록 항산화 활성이 높은 것을 뜻한다. 따라서 상기 표 1에서와 같이, DPPH radical scavenging activity 측정 결과에 따르면 실시예 1, 2의 항산화능은 블루베리에 비하여 월등히 높음을 확인할 수 있었다. The IC 50 value represents the concentration of the extract which reduces the value of the control without the extract by 50%. The smaller the IC 50 value, the higher the antioxidant activity. Therefore, as shown in Table 1, DPPH radical scavenging activity measurement results showed that the antioxidative activities of Examples 1 and 2 were much higher than those of blueberries.
(시험예 2)(Test Example 2)
상기 실시예 1, 2를 통해 제조한 환에 대하여 훈련된 관능평가요원 20명을 대상으로 하여, 맛, 향기, 외관 및 전체적인 기호도를 9점 평점법(1; 매우 나쁘다, 9; 매우 좋다)으로 평가하여 그 평균값을 하기의 표 2에 나타냈다. 대조구는 시중에서 판매되고 있는 청국장환을 구입하여 비교하였다.The flavor, aroma, appearance and overall acceptability of the 20 sensory evaluation personnel trained in the rings prepared in Examples 1 and 2 were evaluated by the 9-point method (1: very bad, 9: very good) And the average value thereof is shown in Table 2 below. The control was purchased and compared with the commercially available Cheonggukjang.
상기 표 2에서 확인할 수 있는 바와 같이, 본 발명의 실시예 1, 는 대조구에 비해 맛, 향기, 외관 및 전체적인 기호도가 높음을 확인할 수 있었다. 이는 섭취시 아로니아의 은은한 향과 풍미가 느껴져 기호도가 상승한 것으로 판단되었다.As can be seen from the above Table 2, Example 1 of the present invention has higher taste, smell, appearance and overall acceptability than the control. It was judged that the taste and flavor of Aromania was felt during ingestion and the degree of preference increased.
이상, 본 발명을 바람직한 실시 예를 사용하여 상세히 설명하였으나, 본 발명의 범위는 특정 실시 예에 한정되는 것은 아니며, 첨부된 특허청구범위에 의하여 해석되어야 할 것이다. 또한, 이 기술분야에서 통상의 지식을 습득한 자라면, 본 발명의 범위에서 벗어나지 않으면서도 많은 수정과 변형이 가능함을 이해하여야 할 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the scope of the present invention is not limited to the disclosed exemplary embodiments. It will also be appreciated that many modifications and variations will be apparent to those skilled in the art without departing from the scope of the invention.
Claims (5)
산약, 오미자, 구기자, 산사육, 맥문동을 포함하는 제1한약재를 건조하고 분쇄하여 한약재 분말을 제조하는 단계와,
숙지황을 물에 20~40분간 침지시킨 후, 쌀막걸리와 혼합하고 가열하여 죽화하는 단계와,
맥아, 당귀, 백출, 백작약, 백봉령을 포함하는 제2한약재에 물을 가하고 가열하여 한약재 추출액을 제조하는 단계와,
상기 죽화한 숙지황, 상기 한약재 분말 및 상기 한약재 추출액, 상기 아로니아 분말 및 건조맥주효모를 혼합하는 단계와,
상기 혼합한 혼합물을 환으로 성형하는 단계를 포함하는 것을 특징으로 하는 아로니아 한방환의 제조방법.
Drying and crushing the Aronia,
Drying and crushing a first medicinal herb which comprises ginseng powder, ginseng powder, ginseng powder, ginseng powder,
A step of immersing Suksanggi in water for 20 to 40 minutes, mixing with rice rice wine,
Preparing a herbal medicine extract solution by adding water to a second herbal medicine material containing malt, Angelica keiskei,
Mixing the above-mentioned mushroom soup, the herbal powder, the herbal extract, the Aronia powder, and the dried beer yeast,
And molding the mixed mixture into a ring.
상기 제1한약재는 길경 및 지각을 더 포함하고,
상기 제2한약재는 어성초 및 속단을 더 포함하는 것을 특징으로 하는 아로니아 한방환의 제조방법.
The method according to claim 1,
Wherein the first herbal medicine material further includes a root diameter and a perception angle,
Wherein the second medicinal herb further comprises a herbicide and a herbicide.
상기 제1한약재는 건조 전, 30~120초간 끓는 물에 살균하는 단계를 포함하는 것을 특징으로 하는 아로니아 한방환의 제조방법.
The method according to claim 1,
And sterilizing the first herbal medicine with boiling water for 30 to 120 seconds before drying.
상기 죽화한 숙지황, 상기 한약재 분말 및 상기 한약재 추출액, 상기 아로니아 분말 및 건조맥주효모를 혼합하는 단계는,
상기 죽화한 숙지황 5~10중량%, 상기 한약재 분말 5~10중량%, 상기 한약재 추출액 5~10중량%, 아로니아 분말 60~80중량% 및 건조맥주효모 3~10중량%의 비율로 혼합하는 것을 특징으로 하는 아로니아 한방환의 제조방법.
The method according to claim 1,
The step of mixing the mushroom soup, the herbal powder and the herbal extract, the Aronia powder and the dry beer yeast,
5 to 10% by weight of the above-mentioned killed medicinal plant, 5 to 10% by weight of the herbal powder, 5 to 10% by weight of the herbal extract, 60 to 80% by weight of Aronia powder and 3 to 10% ≪ / RTI >
A one-sided film produced by the method of any one of claims 1 to 4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160057712A KR101643385B1 (en) | 2016-05-11 | 2016-05-11 | Method for preparing pills with aronia and pills by the method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160057712A KR101643385B1 (en) | 2016-05-11 | 2016-05-11 | Method for preparing pills with aronia and pills by the method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101643385B1 true KR101643385B1 (en) | 2016-07-27 |
Family
ID=56617280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160057712A KR101643385B1 (en) | 2016-05-11 | 2016-05-11 | Method for preparing pills with aronia and pills by the method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101643385B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180047871A (en) | 2016-11-01 | 2018-05-10 | 경희대학교 산학협력단 | Aronia tablet comprising fermented aronia and dietary fiber |
KR20190074943A (en) * | 2017-12-20 | 2019-06-28 | 박성심 | Nutrition pot and production method thereof |
KR20200086914A (en) * | 2019-01-10 | 2020-07-20 | 주식회사농심 | Composition for enhancing immunity, pharmaceutical and functional food having the composition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100705740B1 (en) | 2006-06-13 | 2007-04-09 | 정주양 | Manufacturing process of pill-type cheonggukjang |
KR101083458B1 (en) | 2009-06-30 | 2011-11-16 | 경남도립남해대학 산학협력단 | Preparation method of bioactive pill of aged black garlic showing improving effects on hyperglycemia and insulin resistance |
KR20120017111A (en) * | 2010-08-18 | 2012-02-28 | 배윤주 | A making method of pill using aronia berry extract |
KR20120017109A (en) * | 2010-08-18 | 2012-02-28 | 배윤주 | A making method of pill using aronia power |
KR101552389B1 (en) | 2013-07-26 | 2015-09-10 | 강동연 | Vinegar with Garlic Bead using Barren land Germanium Bamboo Salt and Method for the Same |
KR101548203B1 (en) * | 2015-01-21 | 2015-09-14 | 한방약초힐링 농업회사법인주식회사 | Manufacturing method of ferment pill containing herb and omega |
-
2016
- 2016-05-11 KR KR1020160057712A patent/KR101643385B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100705740B1 (en) | 2006-06-13 | 2007-04-09 | 정주양 | Manufacturing process of pill-type cheonggukjang |
KR101083458B1 (en) | 2009-06-30 | 2011-11-16 | 경남도립남해대학 산학협력단 | Preparation method of bioactive pill of aged black garlic showing improving effects on hyperglycemia and insulin resistance |
KR20120017111A (en) * | 2010-08-18 | 2012-02-28 | 배윤주 | A making method of pill using aronia berry extract |
KR20120017109A (en) * | 2010-08-18 | 2012-02-28 | 배윤주 | A making method of pill using aronia power |
KR101552389B1 (en) | 2013-07-26 | 2015-09-10 | 강동연 | Vinegar with Garlic Bead using Barren land Germanium Bamboo Salt and Method for the Same |
KR101548203B1 (en) * | 2015-01-21 | 2015-09-14 | 한방약초힐링 농업회사법인주식회사 | Manufacturing method of ferment pill containing herb and omega |
Non-Patent Citations (3)
Title |
---|
Effect of anthocyanins on biochemical parameters in rats exposed to Cadmium(Acta biochimica polonica, v.50 no.2, 2003, pp.543-548) |
Influence of l anthocyanins derived from chokeberry extract on glycosylated hemoglobin level in pregnant women withinsulin-dependent diabetes mellitus(Polish Journal of Gynaecological Investigations. 2001. 3(3). 123~125) |
Influence of natural anthocyanins derived from chokeberry extract in the generation of oxidized low density lipoproteins in pregnancies complicated by fetal intrauterine growth retardation of preeclamptic origin-the role of OLAB (Archives of perinatal Medicine. 2003. 9(4), 28~30) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180047871A (en) | 2016-11-01 | 2018-05-10 | 경희대학교 산학협력단 | Aronia tablet comprising fermented aronia and dietary fiber |
KR20190074943A (en) * | 2017-12-20 | 2019-06-28 | 박성심 | Nutrition pot and production method thereof |
KR102123518B1 (en) * | 2017-12-20 | 2020-06-26 | 박성심 | Nutrition pot and production method thereof |
KR20200086914A (en) * | 2019-01-10 | 2020-07-20 | 주식회사농심 | Composition for enhancing immunity, pharmaceutical and functional food having the composition |
KR102159976B1 (en) * | 2019-01-10 | 2020-09-25 | 주식회사농심 | Composition for enhancing immunity, pharmaceutical and functional food having the composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102136052B1 (en) | Composition for Liver Protection Containing Hub Extract and Beverage Thereof | |
CN103610183A (en) | Beverage for preventing excessive internal heat and preparation method thereof | |
KR101643385B1 (en) | Method for preparing pills with aronia and pills by the method | |
WO2014000403A1 (en) | Method for preparing healthcare gingko complex beverage | |
KR102042798B1 (en) | A method for preparing functional pills comprising extracts of natural materials | |
CN103609695A (en) | Yogurt for reducing blood pressure and expelling fire and preparation method of yogurt | |
KR100994196B1 (en) | Method of preparing fermented liquid of garlic and chonggugjang | |
KR101716297B1 (en) | Method drinks for prevent a metabolic syndrome that made by Hericium erinaceus extracts containing crude drugs extracts. | |
CN104305414A (en) | Blueberry juice | |
KR20190057618A (en) | Ripe persimmon jelly comprising herbal ingredients and manufacturing method thereof | |
KR101837158B1 (en) | Meat sauce using fermented rice bran products and manufacturing method thereby | |
KR102452902B1 (en) | Herbal medicinal liquor and its manufacturing method | |
KR20210030100A (en) | Method for manufacturing a crab preserved in soy sauce and a seasoning crab using mulberry soy sauce and a crab preserved in soy sauce and a seasoning crab manufactured by the same | |
KR20120008263A (en) | Manufacturing method of liquid cactus beverage | |
KR101834638B1 (en) | The method of functional korea traditional cracker using the jujube | |
KR20190102493A (en) | A pill for functional food comprising Protaetia brevitarsis seulensis and manufacturing method therof | |
CN107811291A (en) | A kind of preparation method of HERBA DENDROBII ferment | |
KR102082115B1 (en) | Manufacturing method of healthy foods using protaetia brevitarsis | |
KR102010794B1 (en) | Sugarless sweet pumpkin sikhye and its manufacturing method | |
CN113841884A (en) | Formula of instant meal replacement powder for improving nutrient metabolism and preparation method thereof | |
CN108741046B (en) | Tamarind crystal beer cake and preparation method thereof | |
CN106222012A (en) | A kind of fig wine alleviating rheumatism | |
KR20200112527A (en) | Antibacterial sauce and method of manufacturing the same | |
KR102264978B1 (en) | Method for producing pear puree showing the effect of improving dysuria | |
KR102469870B1 (en) | Manufacturing method of ABC juice with added functional ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20190702 Year of fee payment: 4 |